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Anticipated help-seeking for cancer symptoms before and after
the coronavirus pandemic: results from the Onco-barometer
population survey in Spain
Dafina Petrova 1,2,3, Marina Pollán 1,4, Miguel Rodriguez-Barranco 1,2,3, Dunia Garrido5, Josep M. Borrás6,7,8 and
Maria-José Sánchez1,2,3,9
BACKGROUND: The patient interval—the time patients wait before consulting their physician after noticing cancer symptoms—
contributes to diagnostic delays. We compared anticipated help-seeking times for cancer symptoms and perceived barriers to help-
seeking before and after the coronavirus pandemic.
METHODS: Two waves (pre-Coronavirus: February 2020, N= 3269; and post-Coronavirus: August 2020, N= 1500) of the Spanish
Onco-barometer population survey were compared. The international ABC instrument was administered. Pre–post comparisons
were performed using multiple logistic and Poisson regression models.
RESULTS: There was a consistent and significant increase in anticipated times to help-seeking for 12 of 13 cancer symptoms, with
the largest increases for breast changes (OR= 1.54, 95% CI 1.22–1–96) and unexplained bleeding (OR= 1.50, 1.26–1.79).
Respondents were more likely to report barriers to help-seeking in the post wave, most notably worry about what the doctor may
find (OR= 1.58, 1.35–1.84) and worry about wasting the doctor’s time (OR= 1.48, 1.25–1.74). Women and older individuals were
the most affected.
CONCLUSIONS: Participants reported longer waiting times to help-seeking for cancer symptoms after the pandemic. There is an
urgent need for public interventions encouraging people to consult their physicians with symptoms suggestive of cancer and
counteracting the main barriers perceived during the pandemic situation.
British Journal of Cancer https://doi.org/10.1038/s41416-021-01382-1
BACKGROUND
Healthcare systems around the world are under unprecedented
pressure due to the coronavirus pandemic, which has disrupted
prevention and treatment services for non-communicable dis-
eases such as cancer.1 The pandemic has led to a significant
reduction or complete suspension of cancer screening programs
and reassigning of resources from cancer to COVID-19 care.2–4
These disruptions will likely lead to significant delays in cancer
diagnosis and treatment, which will translate into more cases
diagnosed in later stages, with serious implications for patient
survival, quality of life, and healthcare costs.2,5 In support of this
expectation, a notable reduction in the number of cancer
diagnoses during the pandemic has already been documented
in several countries.4,6,7
In European countries, primary care is the gateway to access
health services for symptomatic patients. Unfortunately, experts
have warned that, due to the exceptional burden suffered by
primary care services, delays in responses to suspected cancer
symptoms are inevitable.8,9 The pandemic is likely to impact
negatively all intervals of the diagnostic pathway, including the
patient interval—the time elapsed between symptom onset and
the first consultation with a physician.9
Patients may be less likely to consult for symptoms during the
pandemic due to fear of being infected, limited capacity to use
telemedicine, or diverse perceived barriers.2,8 This delay may be
particularly important in patients experiencing more vague cancer
symptoms such as weight loss, fatigue or changes in bowel
habits8 or in younger patients (e.g. <65) who have family and work
obligations complicated by the pandemic.
Spain has been one of the countries hit hardest by the
coronavirus10 and, hence, an increase in delays along the cancer
care pathway is expected due to the extreme and continuous
pressure exerted on the health system. A nation-wide study
reported coronavirus seroprevalence of 5% in May 202011 and
on February 25, 2020, more than 3,180,000 cases and 68,800
deaths due to COVID-19 were registered.12 A recent study of 37
tertiary centres from all around the country showed that the
number of new cancer patients decreased by 21% during the
first pandemic wave (March–June 2020) compared to the same
period in 2019.7
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Experts recommended that efforts be made to encourage
patients to seek help for potential cancer symptoms during the
pandemic by addressing current delays and barriers to help-
seeking and identifying groups at high risk of delays.9,13 To better
understand the changes that might have occurred after the first
wave of the pandemic, the aim of the current study was to
compare anticipated help-seeking for cancer symptoms and
perceived barriers in the Spanish population before and after
the pandemic.
METHOD
Data were obtained from the Onco-barometer 2020, a population-
based survey conducted by the Spanish Association against
Cancer (www.aecc.es). The Onco-barometer assesses knowledge
and attitudes towards cancer. In 2020, for the first time, the survey
included a module on help-seeking for cancer symptoms. The
original data collection protocol was interrupted by the
announcement of the pandemic and the state of emergency by
the Spanish government (14 March 2020) and was renewed once
conditions allowed. This generated two survey waves: pre-
Coronavirus (10 February 2020 until 13 March 2020, N= 3269
respondents) and post-Coronavirus (24 August 2020 until 08
September 2020, N= 1500 respondents), offering us the oppor-
tunity to measure population-level changes in anticipated help-
seeking.
Computer-assisted interviews were carried out by a specialised
research market company under a contract by the Spanish
Association against Cancer. A two-stage sampling design was
used. First, stratified random sampling proportional to the
population sizes of the Spanish Autonomous Regions was used
for household selection. Then, sampling units were selected by
applying sex and age quotas with one interview per household.
The distribution mobiles/landlines was 50%/50%. Men and
women, 18 years or older, and able to speak Spanish were eligible.
Variables
Anticipated times to help-seeking and perceived barriers were
measured with the internationally validated Awareness and Beliefs
about Cancer (ABC) questionnaire by the International Cancer
Benchmarking Partnership (ICBP).14 For the current study, it was
translated to Spanish and back-translated to English by fluent
speakers of both languages. Where applicable, answer options
were adjusted to the circumstances of the Spanish health system.
The questionnaire was then pilot tested with a small purposive
sample of 10 respondents (50% female) aged 55 or older with
diverse educational backgrounds. No comprehension problems or
other issues arose, so the pilot was interrupted, and no changes
were made to the first version.
Anticipated times to help-seeking
Respondents were asked how long they would wait before
consulting their physician for 13 cancer warning signs. Answers
were unprompted (respondents answered freely) and were then
assigned to one of the categories provided by the ABC
instrument.14 Besides considering each symptom separately,
following previous studies,15–17 we categorised the answers to
each item as ‘delayed’ or ‘not delayed’ and assigned one point for
each ‘delayed’ answer, thereby generating a total delay score for
each respondent (0–13). We are not aware of any national or
international guidelines defining the maximum recommended
time for help-seeking for symptoms compatible with cancer, so
the cut-off used to define a ‘delayed’ answer was waiting >1 week,
based on the distribution of responses for the majority of
symptoms. Alternative cut-offs were also used (see below).
Answers indicating that the respondent would contact another
healthcare professional (0.0–0.3%) were dropped for this calcula-
tion because the delay was not clear.18
Perceived barriers to help-seeking
Respondents were asked whether each of the following reasons
would make them delay consulting their physician: being
embarrassed, being worried about wasting the doctor’s time,
being worried about what the doctor may find, and not having
enough time to go to the doctor.14 Respondents were also asked
what additional barriers would make them delay consulting their
physician. Answers to this question were coded into meaningful
categories by two independent coders who were blind to the
wave each answer belonged to. Disagreements were resolved by
discussion.
A global barrier score was then calculated (0–5), whereby each
respondent was assigned one point for each reported barrier
based on the four predefined questions and the additional barrier
reported in the open-ended question.
Demographic characteristics
Data were collected on sex, age, marital status, socioeconomic
position (categorised in seven groups following the methodology
of the Spanish National Health Survey and the Spanish
Epidemiology Society19), personal history of cancer, and having
a close family member with cancer.
Analyses
Chi-square tests were used to compare the two waves on
categorical items. To investigate the effect of wave on help-
seeking for each symptom and perceived barrier, we computed
unadjusted (OR) and adjusted (adjOR) odds ratios based on
logistic regressions. Adjusted ORs were based on models including
all socio-demographic and cancer history variables as covariates.
To identify general patterns and socio-demographic groups
potentially more vulnerable in the pandemic situation we used
the total delay and barrier scores. In particular, we conducted
multiple Poisson regressions, in which we tested for significant
interactions of wave with sex and age. Sample weights were
applied in all analyses. Sensitivity analyses reported in the
supplement investigated differences in help-seeking times using
alternative delay scores based on cut-offs of 2 and 3 weeks,
respectively, to define delayed responses. In the case of missing
data, analyses were based on complete cases.
RESULTS
Response rate was 64.1% (65.8% in the pre- and 61.0% in the post-
wave). Demographic characteristics of respondents in both waves
are displayed in Table 1. Compared to the pre-wave (N= 3269),
respondents in the post-wave (N= 1500) were more likely to be
male and single.
Anticipated help-seeking
Anticipated help-seeking was generally prompt for most symp-
toms. Importantly, there were differences in the answer distribu-
tions between the pre- and post-waves for virtually all symptoms
(Table 2). These differences became apparent when considering
the cut-off of 1 week, whereby the percentage of respondents
consulting their physician later than a week after symptom onset
increased in a consistent and significant manner from the pre- to
the post-wave for all cancer symptoms, with the exception of
persistent cough or hoarseness (Fig. 1). Overall, the odds of
seeking care later than a week after symptom onset increased by
about 20–50% in the post wave (Table 3). The amount of change
varied by symptom with the largest relative increases observed for
breast changes, unexplained bleeding, and persistent difficulty
swallowing.
Delay scores were higher for respondents who were male,
younger, from a higher socioeconomic position, single (vs. married
and separated/divorced), and had a close family member
diagnosed with cancer (Supplementary Tables S1 and S2). There
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was an effect of wave, which was different depending on sex and
age (Table 4).
Delay scores increased from pre to post more strongly for
women than for men (see also Supplementary Fig. S1). Looking at
the different symptoms, the pre–post difference in the percentage
of respondents who would seek help within a week of symptom
onset was larger for women than for men for all symptoms with
the exception of persistent difficulty in swallowing (Supplemen-
tary Fig. S2). The most pronounced difference was found for
changes in the appearance of a mole: in the pre-wave 65% of
women said they would seek help within a week and this number
fell to 55% in the post wave, whereas for men the difference was
much smaller (a drop of 50% to 48% pre–post, respectively).
Regarding age, delay scores increased significantly from pre to
post for all groups, except for 18–24 and 45–54 years. The increase
was largest among the two oldest groups (55–64 and 65+) (see
also Supplementary Fig. S3).
The results with the alternative delays scores were generally
similar (Supplementary Tables S3 and S4). Because only women
were asked regarding breast changes, we also conducted analyses
not taking this question into account in the delay scores: it did not
change the general pattern of results or the interaction between
wave and sex (Supplementary Tables S5 and S6).
Perceived barriers to help-seeking
Respondents were significantly more likely to report all but one
barrier in the post compared to the pre-wave (Fig. 2). The largest
increases were observed in reporting an additional barrier (adjOR=
1.66, 95% CI 1.44–1.92, p < 0.001), followed by worry about what the
doctor may find (adjOR= 1.58, 95% CI 1.35–1.84, p < 0.001), being
worried about wasting the doctor’s time (adjOR= 1.48, 95% CI
1.25–1.74, p < 0.001), and being embarrassed (adjOR= 1.42, 95% CI
1.11–1.81, p= 0.005). The additional barriers reported included not
perceiving the symptoms as important enough (10% vs. 13% in pre-
vs post-wave, respectively), family or work obligations (6% vs. 7%),
other diverse issues (4% vs. 8%), barriers related to the functioning
of the health system (4% in both waves), and the coronavirus (0%
vs. 2%).
More barriers were reported by respondents who were female,
younger, separated or divorced (vs. married), and had a close
family member diagnosed with cancer (Supplementary Table S2).
There was an effect of wave that was different depending on sex
and age (Table 4). Generally, the number of reported barriers
increased from pre to post and this increase was more
pronounced for women (Supplementary Fig. S1) and older
respondents (Supplementary Fig. S3).
Looking at the different barriers, the percentage of respondents
who endorsed each barrier increased from pre to post among
both men and women, but this increase was notably larger in
women (Supplementary Table S7). There was one exception: the
barrier ‘not having enough time to go to the doctor’ increased
among women (32% to 37%) but decreased slightly among men
(34% to 32%).
Older respondents (e.g. 65+) reported consistent increases from
pre to post on all barriers, especially worry about wasting the
doctor’s time and worry about what the doctor may find (Fig. 3). In
contrast, whereas most barriers increased among younger
respondents (18–44) from pre to post, the percentage of
respondents who reported not having enough time to go to the
doctor decreased in this group.
DISCUSSION
We observed a consistent increase in anticipated help-seeking
times for 12 out of 13 cancer symptoms comparing answers
registered before the coronavirus pandemic was announced to
those gathered 5 months after. In particular, the odds of seeking
care later than a week after symptom onset increased by about
20–50%, with the largest increases for breast changes and
unexplained bleeding. This should be a matter of concern
because breast changes and unexplained bleeding are warning
signs of the most incident cancers in the Spanish population
(breast cancer in females, and colorectal cancer in both sexes,
respectively).20
The changes observed are not large in absolute terms (e.g.
4–9% average increases in the percentage of people who would
not seek help within a week, Fig. 1). However, they would only add
Table 1. Demographic characteristics of respondents and p-values
from chi-square tests comparing the pre and post waves.
Wave p-value
Pre Post
N= 3269 N= 1500
Sex
Male 41.6% 47.6% <0.001
Female 58.4% 52.4%
Age
18–24 years 7.7% 9.7% 0.116
25–34 years 14.0% 13.1%
35–44 years 19.0% 19.6%
45–54 years 18.9% 20.1%
55–64 years 16.1% 15.0%
≥65 years 24.4% 22.6%
Socioeconomic position
GROUP I. Directors and managers of





GROUP II. Directors and managers of





GROUP III. Intermediate occupations:







GROUP V. Supervisors and workers in
qualified technical occupations
8.8% 10.1%
GROUP VI. Qualified workers of the
primary sector and other semi-
qualified workers
28.6% 25.6%
Group VII. Unskilled workers 11.8% 14.2%
Civil status
Married or cohabiting 52.5% 47.9% 0.038
Single 31.7% 36.1%




No 90.6% 91.1% 0.628
Yes 9.4% 8.9%
Close family member with cancer
No 26.3% 24.5% 0.176
Yes 73.7% 75.5%
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Table 2. Responses to the question ‘How long would you wait to consult your physician from the moment you detect the symptom for the first
time?’ for 13 possible cancer warning signs as a function of wave (pre vs. post).
Unexplained
bleeding




Wave Wave Wave Wave
Pre Post Pre Post Pre Post Pre Post
N= 3269 N= 1500 N= 1913 N= 796 N= 3269 N= 1500 N= 3269 N= 1500
I would go as soon as I noticed 68.8% 60.6% 73.5% 64.1% 55.1% 46.4% 43.3% 36.8%
Within 1 week 16.4% 19.7% 12.2% 14.9% 17.3% 21.0% 24.6% 23.2%
Between 1 and 2 weeks 10.6% 14.8% 9.2% 14.7% 17.6% 21.0% 20.2% 27.6%
Between 2 and 3 weeks 1.5% 2.0% 1.7% 1.7% 3.7% 5.0% 4.1% 4.7%
Between 3 and 4 weeks 0.7% 0.8% 0.9% 2.0% 2.0% 2.7% 2.3% 2.8%
More than a month 0.8% 1.0% 1.4% 1.8% 3.1% 2.6% 2.3% 2.3%
I would not contact my physician about this 0.6% 0.5% 0.4% 0.4% 0.7% 0.5% 1.9% 2.0%
I would contact another healthcare professional 0.0% 0.0% 0.1% 0.0% 0.1% 0.1% 0.1%
Does not respond 0.6% 0.6% 0.6% 0.4% 0.5% 0.7% 1.1% 0.5%




appearance of a mole
A sore that does
not heal
Abdominal swelling
Wave Wave Wave Wave
Pre Post Pre Post Pre Post Pre Post
N= 3269 N= 1500 N= 3269 N= 1500 N= 3269 N= 1500 N= 3269 N= 1500
I would go as soon as I noticed 41.3% 34.5% 42.7% 35.5% 33.8% 28.2% 29.4% 27.0%
Within 1 week 21.9% 22.9% 15.7% 15.2% 20.2% 19.4% 21.5% 19.0%
Between 1 and 2 weeks 22.2% 27.5% 19.2% 22.1% 27.1% 31.0% 25.5% 30.3%
Between 2 and 3 weeks 4.9% 6.8% 6.1% 7.8% 8.6% 10.2% 7.8% 8.0%
Between 3 and 4 weeks 3.1% 3.4% 5.1% 6.7% 4.2% 4.8% 4.2% 4.9%
More than a month 3.9% 3.0% 7.4% 7.6% 3.6% 3.8% 5.5% 5.6%
I would not contact my physician about this 1.6% 0.9% 2.9% 3.3% 1.8% 1.5% 5.0% 4.4%
I would contact another healthcare professional 0.1% 0.0% 0.0% 0.1% 0.1% 0.3% 0.1%
Does not respond 1.0% 0.9% 1.0% 1.7% 0.6% 0.8% 1.1% 0.8%
Chi2 test p-value <0.001 <0.001 .001 0.019








Wave Wave Wave Wave
Pre Post Pre Post Pre Post Pre Post
N= 3269 N= 1500 N= 3269 N= 1500 N= 3269 N= 1500 N= 3269 N= 1500
I would go as soon as I noticed 31.1% 26.0% 31.2% 25.5% 17.5% 17.3% 18.4% 15.2%
Within 1 week 18.3% 18.0% 11.7% 10.9% 17.0% 16.0% 15.4% 14.7%
Between 1 and 2 weeks 25.3% 29.9% 20.5% 24.5% 30.7% 28.5% 24.7% 27.5%
Between 2 and 3 weeks 8.6% 9.1% 10.1% 11.0% 9.9% 13.5% 8.8% 10.3%
Between 3 and 4 weeks 5.3% 7.8% 8.8% 12.7% 6.4% 9.9% 6.4% 9.5%
More than a month 6.4% 5.6% 11.3% 9.5% 9.6% 7.2% 9.8% 8.8%
I would not contact my physician about this 3.7% 2.7% 4.8% 4.4% 7.9% 6.5% 13.8% 11.1%
I would contact another healthcare professional 0.1% 0.3% 0.0% 0.1% 0.2% 0.2% 0.1% 0.4%
Does not respond 1.3% 0.6% 1.5% 1.3% 0.7% 1.1% 2.6% 2.4%
Chi2 test p-value <0.001 <0.001 <0.001 0.001
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further delays to those produced on the other intervals of the
cancer care pathway (e.g. waiting times until the appointment
with the physician, referral, diagnostic investigations, and treat-
ment scheduling delays).9,21
The only symptom for which no increase was observed was
persistent cough or hoarseness. The reason may be related to the
pandemic, since the population is aware that cough is also a
symptom of COVID-19, and this would speed up help-seeking.
Actually, using 4-weeks as a cut-off for this symptom following
previous studies,18 we observed a decrease in the number of
people who would wait beyond this period (17.5% pre to
13.7% post).
Given the lack of official guidelines regarding the maximum
time recommended to wait before seeking help for symptoms
compatible with cancer, previous research has used a variety of
cut-offs to define delayed responses (ranging from 1 to 4 weeks),
based on the distribution of responses or the urgency of
symptoms. For this reason, we conducted sensitivity analyses
using different cut-offs (reported in the Supplement). Although
the global scores based on the 2-week cut-off reliably detected
the pre–post-pandemic changes, as can be seen in Fig. 1, pre–post
differences were most pronounced considering the cut-off of
1 week. This shows that the documented increases in the time it
would take to seek help are not large in terms of the number of
days or weeks most individuals would wait.
However, we believe they are of the highest concern because
anticipated help-seeking times reported in general population
surveys tend to be very optimistic in comparison to real help-
seeking times reported by patients who experienced symptoms.
Whereas the majority of survey participants report they would
seek help within a week of symptom onset for most cancer
symptoms, it is not uncommon for cancer patients to report
having waited more than a month to consult with a healthcare
professional.22 For instance, in the study by Lyratzopoulos, the
proportion of patients who waited more than a month was at least
25% for 22 out of 28 cancers.23
Respondents were generally more likely to report barriers
5 months after the pandemic started, suggesting that there may
be a general perception of lower availability of healthcare services.
In the post-wave, more respondents were worried about wasting
the doctor’s time, suggesting that in the current circumstances
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Fig. 1 Anticipated help-seeking as a function of wave. Percentage of respondents reporting anticipated help-seeking times within the




N= 3269 N= 1500
I would go as soon as I noticed 19.6% 16.8%
Within 1 week 14.1% 12.7%
Between 1 and 2 weeks 25.7% 29.5%
Between 2 and 3 weeks 10.5% 12.3%
Between 3 and 4 weeks 8.8% 11.0%
More than a month 11.7% 10.4%
I would not contact my physician about this 8.1% 6.3%
I would contact another healthcare professional 0.2% 0.0%
Does not respond 1.3% 1.0%
Chi2 test p-value <0.001
The chi2 test tests for differences in the distribution of responses between the pre and post waves.
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absolutely necessary. However, the percentage of people who
reported worry about what the doctor may find also increased in
the post wave, suggesting that there could be an overall increase
in health-related concern in the general population. These
perceived barriers should be investigated further and addressed
in the population because they are important drivers of help-
seeking.16,18 Interestingly, only 2% of respondents mentioned the
coronavirus as a barrier to help-seeking and it was not singled out
as the main reason for delays in help-seeking.
In the pre-wave, women reported faster help-seeking times
than men, consistent with the documented higher reluctance of
men to consult for diverse health problems.24 However, this
advantage disappeared in the post wave, where both women’s
delay and barrier scores increased to a larger extent than men’s. If
this pattern persists, in the long-term women’s cancer outcomes
might be disproportionately negatively affected by the pandemic
situation. The analysis of specific symptoms showed that pre–post
differences for women were especially pronounced for the skin
cancer symptom (changes in the appearance of a mole),
suggesting that women could be at high risk of delayed diagnosis
for this cancer. Additional delays and barriers to help-seeking may
be a result of the larger burden of the pandemic on the female
population25 in terms of coping with work and family obligations,
which emerge as competing goals.26 This supposition is supported
by the finding that the percentage of women who reported not
having time to go to the doctor increased in the post wave,
whereas it decreased in men.
An encouraging finding is that consistent with previous
research,16,18,27 the population with the highest cancer incidence
(older adults +65 years old), reported the fastest help-seeking
times and the fewest barriers. However, both help-seeking times
and perceived barriers increased to a larger extent in this group
(e.g. a median of 0 barriers in the pre vs. median of 1 in the
post wave).
The increase in help-seeking times for younger and middle-
aged adults is also worrying because recent modelling studies
show that it is precisely younger patients who would be most
affected by the COVID-19-related delays in the cancer care
pathway.28 In particular, survival decrements for even small
diagnostic delays are expected to be substantial for most tumours
in individuals under 70.28
To the best of our knowledge, this is the first population-based
survey to investigate anticipated help-seeking for cancer symp-
toms in Spain. Despite the increases documented after the start of
the pandemic, anticipated help-seeking times in Spain remain
generally prompt and similar (e.g. Australia, Canada, Sweden) or
notably quicker (e.g. UK and Denmark) than those documented in
high-income countries of the ICBP.16,18 The exception is breast
changes, with post-pandemic help-seeking times (20% seeking
help >1 week) notably longer than those documented in all but
one country of the ICBP.18 This is especially worrying due to the
suspension of the organised breast screening programs in many
Spanish regions. In contrast, in comparison to residents of the
other ICBP countries (with the exception of the UK),29 Spaniards
report more barriers to help-seeking.
Limitations of this research include potential selection biases
related to survey non-response, a smaller sample in the post
compared to the pre-wave, and some differences in the socio-
demographic characteristics of the respondents in the two waves.
The pre-wave data collection took place immediately before the
state of emergency was announced when the coronavirus was
already a serious problem in Spain. Thus, it is possible that the
reported help-seeking times and barriers in the pre-wave may
already have been affected by the coronavirus crisis.
It is not clear to what extent anticipated help-seeking times are
indicative of actual help-seeking times for experienced symptoms,
although results tend to be similar across studies regarding drivers
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Fig. 2 Perceived barriers as a function of wave. Percentage of respondents reporting different barriers to help-seeking for symptoms as a





























































































I would be worried about wasting
the doctor's time
I would be worried about what the
doctor might find




Fig. 3 Perceived barriers according to age group. Percentage of respondents reporting different barriers to help-seeking for symptoms as a
function of wave (pre vs. post) and age group.
Table 4. Relative score increases (RSI) for the effect of wave in different demographic groups derived from multiple Poisson regression analyses with
interaction terms on total delay scores and total barrier scores.
Delay scores Barrier scores
95% CI 95% CI
RSI Lower Upper p RSI Lower Upper p
Sex
Males 1.07 1.03 1.11 0.001 1.18 1.08 1.30 <0.001
Females 1.14 1.10 1.18 <0.001 1.34 1.24 1.45 <0.001
Age
18–24 1.02 0.93 1.11 0.673 1.17 0.96 1.41 0.114
25–34 1.08 1.01 1.15 0.025 1.13 0.98 1.31 0.084
35–44 1.12 1.06 1.19 <0.001 1.21 1.06 1.39 0.006
45–54 1.05 0.99 1.12 0.123 1.19 1.04 1.37 0.013
55–64 1.21 1.13 1.30 <0.001 1.30 1.10 1.53 0.002
65+ 1.17 1.10 1.25 <0.001 1.73 1.49 1.99 <0.001
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however, it was not previously validated for use in Spain or any
other Southern-European or Spanish-speaking country, so mea-
surement problems may exist. In addition, because it was not
created specifically for the Spanish culture and health system, we
had to adapt some answer options and included an open-ended
question about barriers to capture issues beyond the predefined
questionnaire. For instance, competing family and work obliga-
tions emerged as an additional frequent barrier to help-seeking
that was not considered in the original questionnaire.
The results of this population survey in Spain provide the first
evidence in support of the anticipated increases in help-
seeking times for cancer symptoms during the coronavirus
pandemic.2,8,9 The results suggest that there is an urgent need
for interventions encouraging people to consult their physicians
with symptoms suggestive of cancer and addressing the barriers
that have become most pronounced during the pandemic
situation, especially among women and older individuals.9,13
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